In addition, AOZNs induced a strong antitumor immune response in the B16F10 model, resensitized tumors to anti‐PD‐L1 therapy through the enhancement of PD‐L1 expression, and efficiently regressed tumor growth.[119]. Here, CD274 is linked to neoplasm.